<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36322364</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>15</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1534-3170</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>12</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Current cardiology reports</Title><ISOAbbreviation>Curr Cardiol Rep</ISOAbbreviation></Journal><ArticleTitle>Cardiac Manifestations of Post-Acute COVID-19 Infection.</ArticleTitle><Pagination><StartPage>1775</StartPage><EndPage>1783</EndPage><MedlinePgn>1775-1783</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11886-022-01793-3</ELocationID><Abstract><AbstractText Label="PURPOSE OF REVIEW">There is emerging evidence that the post-acute and chronic phases of COVID-19 infection are associated with various significant cardiovascular sequelae.</AbstractText><AbstractText Label="RECENT FINDINGS">Long COVID has been shown to be associated with multiple cardiovascular sequelae including direct myocardial injury, arrhythmias, and cardiomyopathies. Hypotheses on the mechanism of myocardial injury include direct viral infiltration and autoimmune dysregulation. Long COVID is associated with persistent cardiac ischemia in patients with no previous history of coronary disease, atrial and ventricular arrhythmias, and the development of new-onset heart failure in previously healthy patients. Onset of long COVID may be related to severity of the initial SARS-CoV2 infection. Cardiac MRI is a valuable tool in assessing myocarditis and the development of cardiomyopathies in the setting of long COVID. Both patients with and without pre-existing cardiovascular disease are at risk of developing myocardial injury in the setting of long COVID. Future studies will elucidate both cardiovascular mortality and cardiac rehabilitation in the post-acute and chronic phases of COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohammad</LastName><ForeName>Khan O</ForeName><Initials>KO</Initials><Identifier Source="ORCID">0000-0003-1131-0584</Identifier><AffiliationInfo><Affiliation>Department of Internal Medicine, Dell Medical School at The University of Texas, 1500 Red River St., Austin, TX, 78701, USA. ko.mohammad@utexas.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Medicine, University of California San Diego, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodriguez</LastName><ForeName>Jose B Cruz</ForeName><Initials>JBC</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Medicine, University of California San Diego, San Diego, CA, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Curr Cardiol Rep</MedlineTA><NlmUniqueID>100888969</NlmUniqueID><ISSNLinking>1523-3782</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006321" MajorTopicYN="N">Heart</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001145" MajorTopicYN="N">Arrhythmias, Cardiac</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Cardiovascular disease</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>2</Day><Hour>12</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36322364</ArticleId><ArticleId IdType="pmc">PMC9628458</ArticleId><ArticleId IdType="doi">10.1007/s11886-022-01793-3</ArticleId><ArticleId IdType="pii">10.1007/s11886-022-01793-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anka AU, Tahir MI, Abubakar SD, et al. Coronavirus disease 2019 (COVID-19): an overview of the immunopathology, serological diagnosis and management. Scand J Immunol. 2021;93(4):e12998. doi: 10.1111/sji.12998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12998</ArticleId><ArticleId IdType="pmc">PMC7744910</ArticleId><ArticleId IdType="pubmed">33190302</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19. London: National Institute for Health and Care Excellence (NICE); 2020 Dec 18. (NICE Guideline, No. 188.) Available from: https://www.ncbi.nlm.nih.gov/books/NBK567261/</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583&#x2013;590. doi: 10.1038/s41591-022-01689-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhan Y, Zhu Y, Wang S, et al. SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection. Signal Transduct Target Ther. 2021;6(1):368. doi: 10.1038/s41392-021-00777-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00777-z</ArticleId><ArticleId IdType="pmc">PMC8512652</ArticleId><ArticleId IdType="pubmed">34645784</ArticleId></ArticleIdList></Reference><Reference><Citation>Nune A, Durkowski V, Titman A, et al. Incidence and risk factors of long COVID in the UK: a single-centre observational study. J R Coll Physicians Edinb. 2021;51(4):338&#x2013;343. doi: 10.4997/JRCPE.2021.405.</Citation><ArticleIdList><ArticleId IdType="doi">10.4997/JRCPE.2021.405</ArticleId><ArticleId IdType="pubmed">34882130</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Dercon Q, Luciano S, Geddes JR, Husain M, Harrison PJ. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18(9):e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, Lifelines Corona Research Initiative Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400(10350):452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Gonz&#xe1;lez A, Ara&#xfa;jo-Ameijeiras A, Fern&#xe1;ndez-Villar A, Crespo M, Poveda E, Cohort COVID-19 of the Galicia Sur Health Research Institute Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study. Sci Rep. 2022;12(1):3369. doi: 10.1038/s41598-022-07414-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-07414-x</ArticleId><ArticleId IdType="pmc">PMC8888560</ArticleId><ArticleId IdType="pubmed">35233035</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Kapur S, et al. Multi-organ impairment in low-risk individuals with long COVID. BMJ. 2020 doi: 10.1101/2020.10.14.20212555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.14.20212555</ArticleId></ArticleIdList></Reference><Reference><Citation>Kini A, Cao D, Nardin M, et al. Types of myocardial injury and mid-term outcomes in patients with COVID-19. Eur Heart J Qual Care Clin Outcomes. 2021;7(5):438&#x2013;446. doi: 10.1093/ehjqcco/qcab053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjqcco/qcab053</ArticleId><ArticleId IdType="pubmed">34458912</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Izquierdo M, L&#xe1;inez-Ramos-Bossini AJ, de Alba IG, et al. Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes-a multicentre cohort study. BMC Med. 2022;20(1):92. doi: 10.1186/s12916-022-02292-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02292-6</ArticleId><ArticleId IdType="pmc">PMC8863509</ArticleId><ArticleId IdType="pubmed">35193574</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Ayoubkhani D, Bermingham C, Pouwels KB, et al. Trajectory of long COVID symptoms after COVID-19 vaccination: community based cohort study. BMJ. 2022;377:e069676. 10.1136/bmj-2021-069676. A large observational cohort study in the UK showed that the incidence of long COVID was significantly decreased in patients who received COVID-19 vaccination.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat Med. 2022;28(7):1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260&#x2013;1263. doi: 10.1126/science.abb2507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2507</ArticleId><ArticleId IdType="pmc">PMC7164637</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005;11(8):875&#x2013;879. doi: 10.1038/nm1267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1267</ArticleId><ArticleId IdType="pmc">PMC7095783</ArticleId><ArticleId IdType="pubmed">16007097</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwasaki M, Saito J, Zhao H, Sakamoto A, Hirota K, Ma D. Inflammation triggered by SARS-CoV-2 and ACE2 augment drives multiple organ failure of severe COVID-19: molecular mechanisms and implications. Inflammation. 2021;44(1):13&#x2013;34. doi: 10.1007/s10753-020-01337-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-020-01337-3</ArticleId><ArticleId IdType="pmc">PMC7541099</ArticleId><ArticleId IdType="pubmed">33029758</ArticleId></ArticleIdList></Reference><Reference><Citation>Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med. 2010;2(7):247&#x2013;257. doi: 10.1002/emmm.201000080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201000080</ArticleId><ArticleId IdType="pmc">PMC3377325</ArticleId><ArticleId IdType="pubmed">20597104</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaebler C, Wang Z, Lorenzi JCC, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591(7851):639&#x2013;644. doi: 10.1038/s41586-021-03207-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03207-w</ArticleId><ArticleId IdType="pmc">PMC8221082</ArticleId><ArticleId IdType="pubmed">33461210</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian S, Xiong Y, Liu H, et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol. 2020;33(6):1007&#x2013;1014. doi: 10.1038/s41379-020-0536-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41379-020-0536-x</ArticleId><ArticleId IdType="pmc">PMC7156231</ArticleId><ArticleId IdType="pubmed">32291399</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang EY, Mao T, Klein J, et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595(7866):283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Boucher A, Desforges M, Duquette P, Talbot PJ. Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patients. Clin Immunol. 2007;123(3):258&#x2013;267. doi: 10.1016/j.clim.2007.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2007.02.002</ArticleId><ArticleId IdType="pmc">PMC7106099</ArticleId><ArticleId IdType="pubmed">17448727</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsson AC, Humbert M, Buggert M. The known unknowns of T cell immunity to COVID-19. Sci Immunol. 2020;5(53):eabe8063. doi: 10.1126/sciimmunol.abe8063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abe8063</ArticleId><ArticleId IdType="pubmed">33208380</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K, Patra T, Vijayamahantesh, Ray R. SARS-CoV-2 spike protein induces paracrine senescence and leukocyte adhesion in endothelial cells. J Virol. 2021;95(17):e0079421. 10.1128/JVI.00794-21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8354225</ArticleId><ArticleId IdType="pubmed">34160250</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Y, Zhang J, Schiavon CR, et al. SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2. Circ Res. 2021;128(9):1323&#x2013;1326. doi: 10.1161/CIRCRESAHA.121.318902.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.318902</ArticleId><ArticleId IdType="pmc">PMC8091897</ArticleId><ArticleId IdType="pubmed">33784827</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Lu S, Tang AF, et al. Markers of immune activation and inflammation in individuals with postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. J Infect Dis. 2021;224(11):1839&#x2013;1848. doi: 10.1093/infdis/jiab490.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab490</ArticleId><ArticleId IdType="pmc">PMC8643408</ArticleId><ArticleId IdType="pubmed">34677601</ArticleId></ArticleIdList></Reference><Reference><Citation>Saad M, Kennedy KF, Imran H, et al. Association between COVID-19 diagnosis and in-hospital mortality in patients hospitalized with ST-segment elevation myocardial infarction. JAMA. 2021;326(19):1940&#x2013;1952. doi: 10.1001/jama.2021.18890.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.18890</ArticleId><ArticleId IdType="pmc">PMC8596198</ArticleId><ArticleId IdType="pubmed">34714327</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D, Khunti K, Nafilyan V, et al. Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study. BMJ. 2021;372:n693. doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi B, Kumar V, Kalra A, et al. Influence of influenza infection on in-hospital acute myocardial infarction outcomes. Am J Cardiol. 2020;130:7&#x2013;14. doi: 10.1016/j.amjcard.2020.05.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjcard.2020.05.045</ArticleId><ArticleId IdType="pubmed">32636019</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudry FA, Rathod KS, Baumbach A, Mathur A, Jones DA. Long-term outcomes of COVID-19 associated ST-elevation myocardial infarction treated with primary PCI [published online ahead of print, 2022 May 25]. Cardiovasc Revasc Med. 2022;S1553&#x2013;8389(22)00280&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9132431</ArticleId><ArticleId IdType="pubmed">35637125</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotecha T, Knight DS, Razvi Y, et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J. 2021;42(19):1866&#x2013;1878. doi: 10.1093/eurheartj/ehab075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehab075</ArticleId><ArticleId IdType="pmc">PMC7928984</ArticleId><ArticleId IdType="pubmed">33596594</ArticleId></ArticleIdList></Reference><Reference><Citation>Italia L, Ingallina G, Napolano A, et al. Subclinical myocardial dysfunction in patients recovered from COVID-19. Echocardiography. 2021;38(10):1778&#x2013;1786. doi: 10.1111/echo.15215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/echo.15215</ArticleId><ArticleId IdType="pmc">PMC8652678</ArticleId><ArticleId IdType="pubmed">34672005</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrow AJ, Sykes R, McIntosh A, et al. A multisystem, cardio-renal investigation of post-COVID-19 illness. Nat Med. 2022;28(6):1303&#x2013;1313. doi: 10.1038/s41591-022-01837-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01837-9</ArticleId><ArticleId IdType="pmc">PMC9205780</ArticleId><ArticleId IdType="pubmed">35606551</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendrickson BS, Stephens RE, Chang JV, et al. Cardiovascular evaluation after COVID-19 in 137 collegiate athletes: results of an algorithm-guided screening. Circulation. 2021;143(19):1926&#x2013;1928. doi: 10.1161/CIRCULATIONAHA.121.053982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.053982</ArticleId><ArticleId IdType="pubmed">33970675</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594(7862):259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty SE, Guo Y, Heath K, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021;373:n1098. doi: 10.1136/bmj.n1098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Romero-Duarte &#xc1;, Rivera-Izquierdo M, Guerrero-Fern&#xe1;ndez de Alba I, et al. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med. 2021;19(1):129. 10.1186/s12916-021-02003-7. A retrospective observational study in Spain showing that 3.1% of patients with long COVID were found to have an identifiable arrhythmia or symptomatic palpitations 6 months after the index SARS-CoV2 infection.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8134820</ArticleId><ArticleId IdType="pubmed">34011359</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Wong CK, Un KC, et al. Cardiovascular sequalae in uncomplicated COVID-19 survivors. PLoS ONE. 2021;16(2):e0246732. doi: 10.1371/journal.pone.0246732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0246732</ArticleId><ArticleId IdType="pmc">PMC7877588</ArticleId><ArticleId IdType="pubmed">33571321</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long COVID [published correction appears in Nat Med. 2021 Jun; 27(6):1116] Nat Med. 2021;27(4):626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27(1):89&#x2013;95. doi: 10.1016/j.cmi.2020.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya AA, Akbari A, Emami A, et al. Risk factors associated with long COVID syndrome: a retrospective study. Iran J Med Sci. 2021;46(6):428&#x2013;436. doi: 10.30476/ijms.2021.92080.2326.</Citation><ArticleIdList><ArticleId IdType="doi">10.30476/ijms.2021.92080.2326</ArticleId><ArticleId IdType="pmc">PMC8611223</ArticleId><ArticleId IdType="pubmed">34840383</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingul CB, Grimsmo J, Mecinaj A, et al. Cardiac dysfunction and arrhythmias 3 months after hospitalization for COVID-19. J Am Heart Assoc. 2022;11(3):e023473. doi: 10.1161/JAHA.121.023473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.121.023473</ArticleId><ArticleId IdType="pmc">PMC9238505</ArticleId><ArticleId IdType="pubmed">35048715</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Pellot I, Kim M, Cho JH, Cingolani E. The incidence of cardiac arrhythmias in patients with COVID-19: a meta-analysis. J Am Coll Cardiol. 2022;79(9_Supplement):2143. doi: 10.1016/S0735-1097(22)03134-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0735-1097(22)03134-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Peretto G, Sala S, Rizzo S, et al. Ventricular arrhythmias in myocarditis: characterization and relationships with myocardial inflammation. J Am Coll Cardiol. 2020;75(9):1046&#x2013;1057. doi: 10.1016/j.jacc.2020.01.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.01.036</ArticleId><ArticleId IdType="pubmed">32138965</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman BP, Khoury JA, Blair JE, Grill MF. COVID-19 dysautonomia. Front Neurol. 2021;12:624968. doi: 10.3389/fneur.2021.624968.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.624968</ArticleId><ArticleId IdType="pmc">PMC8076737</ArticleId><ArticleId IdType="pubmed">33927679</ArticleId></ArticleIdList></Reference><Reference><Citation>Buoite Stella A, Furlanis G, Frezza NA, Valentinotti R, Ajcevic M, Manganotti P. Autonomic dysfunction in post-COVID patients with and witfhout neurological symptoms: a prospective multidomain observational study. J Neurol. 2022;269(2):587&#x2013;596. doi: 10.1007/s00415-021-10735-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10735-y</ArticleId><ArticleId IdType="pmc">PMC8359764</ArticleId><ArticleId IdType="pubmed">34386903</ArticleId></ArticleIdList></Reference><Reference><Citation>Dweck MR, Bularga A, Hahn RT, Bing R, Lee KK, Chapman AR, et al. Global evaluation of echocardiography in patients with COVID-19. Eur Heart J Cardiovasc Imaging. 2020;21(9):949&#x2013;958. doi: 10.1093/ehjci/jeaa178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeaa178</ArticleId><ArticleId IdType="pmc">PMC7337658</ArticleId><ArticleId IdType="pubmed">32556199</ArticleId></ArticleIdList></Reference><Reference><Citation>Maestre-Mu&#xf1;iz MM, Arias &#xc1;, Mata-V&#xe1;zquez E, et al. Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J Clin Med. 2021;10(13):2945. doi: 10.3390/jcm10132945.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10132945</ArticleId><ArticleId IdType="pmc">PMC8269002</ArticleId><ArticleId IdType="pubmed">34209085</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, McAuley H, Harrison EM, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study [published correction appears in Lancet Respir Med. 2022 Jan; 10(1):e9] Lancet Respir Med. 2021;9(11):1275&#x2013;1287. doi: 10.1016/S2213-2600(21)00383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00383-0</ArticleId><ArticleId IdType="pmc">PMC8497028</ArticleId><ArticleId IdType="pubmed">34627560</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao TC, Huang YW, Chang SM, Tsai SY, Wu AC, Tsai HJ. Association between oral corticosteroid bursts and severe adverse events : a nationwide population-based cohort study. Ann Intern Med. 2020;173(5):325&#x2013;330. doi: 10.7326/M20-0432.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-0432</ArticleId><ArticleId IdType="pubmed">32628532</ArticleId></ArticleIdList></Reference><Reference><Citation>Moody WE, Liu B, Mahmoud-Elsayed HM, et al. Persisting adverse ventricular remodeling in COVID-19 survivors: a longitudinal echocardiographic study. J Am Soc Echocardiogr. 2021;34(5):562&#x2013;566. doi: 10.1016/j.echo.2021.01.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.echo.2021.01.020</ArticleId><ArticleId IdType="pmc">PMC8008825</ArticleId><ArticleId IdType="pubmed">33539950</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnweber T, Sahanic S, Pizzini A, et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57(4):2003481. doi: 10.1183/13993003.03481-2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03481-2020</ArticleId><ArticleId IdType="pmc">PMC7736754</ArticleId><ArticleId IdType="pubmed">33303539</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Wang H, Zhao R, et al. Elevated extracellular volume fraction and reduced global longitudinal strains in participants recovered from COVID-19 without clinical cardiac findings. Radiology. 2021;299(2):E230&#x2013;E240. doi: 10.1148/radiol.2021203998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021203998</ArticleId><ArticleId IdType="pmc">PMC7808090</ArticleId><ArticleId IdType="pubmed">33434112</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xfc;nay N, Demir&#xf6;z &#xd6;, Kahyao&#x11f;lu M, et al. The effect of moderate and severe COVID-19 pneumonia on short-term right ventricular functions: a prospective observational single pandemic center analysis. Int J Cardiovasc Imaging. 2021;37(6):1883&#x2013;1890. doi: 10.1007/s10554-021-02171-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10554-021-02171-w</ArticleId><ArticleId IdType="pmc">PMC7868518</ArticleId><ArticleId IdType="pubmed">33555535</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirokov NE, Yaroslavskaya EI, Krinochkin DV, Osokina NA. Hidden systolic dysfunction of the right ventricle in patients with increased pulmonary vascular resistance 3 months after COVID-19 pneumonia. Kardiologiia. 2022;62(3):16&#x2013;20. 10.18087//cardio.2022.3.n1743.</Citation><ArticleIdList><ArticleId IdType="pubmed">35414355</ArticleId></ArticleIdList></Reference><Reference><Citation>Pel&#xe0; G, Goldoni M, Cavalli C, et al. Long-term cardiac sequelae in patients referred into a diagnostic post-COVID-19 pathway: the different impacts on the right and left ventricles. Diagnostics (Basel). 2021;11(11):2059. doi: 10.3390/diagnostics11112059.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics11112059</ArticleId><ArticleId IdType="pmc">PMC8623572</ArticleId><ArticleId IdType="pubmed">34829406</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A, Wamil M, Alberts J, et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3):e048391. doi: 10.1136/bmjopen-2020-048391.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-048391</ArticleId><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Dweck MR, Bularga A, Hahn RT, et al. Global evaluation of echocardiography in patients with COVID-19. Eur Heart J Cardiovasc Imaging. 2020;21(9):949&#x2013;958. doi: 10.1093/ehjci/jeaa178.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjci/jeaa178</ArticleId><ArticleId IdType="pmc">PMC7337658</ArticleId><ArticleId IdType="pubmed">32556199</ArticleId></ArticleIdList></Reference><Reference><Citation>Scally C, Rudd A, Mezincescu A, et al. Persistent long-term structural, functional, and metabolic changes after stress-Induced (Takotsubo) cardiomyopathy. Circulation. 2018;137(10):1039&#x2013;1048. doi: 10.1161/CIRCULATIONAHA.117.031841.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.117.031841</ArticleId><ArticleId IdType="pmc">PMC5841855</ArticleId><ArticleId IdType="pubmed">29128863</ArticleId></ArticleIdList></Reference><Reference><Citation>Basso C, Leone O, Rizzo S, et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur Heart J. 2020;41(39):3827&#x2013;3835. doi: 10.1093/eurheartj/ehaa664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa664</ArticleId><ArticleId IdType="pmc">PMC7543528</ArticleId><ArticleId IdType="pubmed">32968776</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) [published correction appears in JAMA Cardiol. 2020 Nov 1;5(11):1308] JAMA Cardiol. 2020;5(11):1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Cassar MP, Tunnicliffe EM, et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. EClinicalMedicine. 2021;31:100683. doi: 10.1016/j.eclinm.2020.100683.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100683</ArticleId><ArticleId IdType="pmc">PMC7808914</ArticleId><ArticleId IdType="pubmed">33490928</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng MY, Ferreira VM, Leung ST, et al. Patients recovered from COVID-19 show ongoing subclinical myocarditis as revealed by cardiac magnetic resonance imaging. JACC Cardiovasc Imaging. 2020;13(11):2476&#x2013;2478. doi: 10.1016/j.jcmg.2020.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.08.012</ArticleId><ArticleId IdType="pmc">PMC7455163</ArticleId><ArticleId IdType="pubmed">33153536</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Li R, Zhou Z, et al. Cardiac involvement in COVID-19 patients: mid-term follow up by cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2021;23(1):14. doi: 10.1186/s12968-021-00710-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-021-00710-x</ArticleId><ArticleId IdType="pmc">PMC7904320</ArticleId><ArticleId IdType="pubmed">33627143</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajpal S, Tong MS, Borchers J, et al. Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19 infection [published correction appears in JAMA Cardiol. 2021 Jan 1;6(1):123] JAMA Cardiol. 2021;6(1):116&#x2013;118. doi: 10.1001/jamacardio.2020.4916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.4916</ArticleId><ArticleId IdType="pmc">PMC7489396</ArticleId><ArticleId IdType="pubmed">32915194</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma&#x142;ek &#x141;A, Marczak M, Mi&#x142;osz-Wieczorek B, et al. Cardiac involvement in consecutive elite athletes recovered from Covid-19: a magnetic resonance study. J Magn Reson Imaging. 2021;53(6):1723&#x2013;1729. doi: 10.1002/jmri.27513.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.27513</ArticleId><ArticleId IdType="pmc">PMC8014772</ArticleId><ArticleId IdType="pubmed">33474768</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels CJ, Rajpal S, Greenshields JT, et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the Big Ten COVID-19 Cardiac Registry. JAMA Cardiol. 2021;6(9):1078&#x2013;1087. doi: 10.1001/jamacardio.2021.2065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.2065</ArticleId><ArticleId IdType="pmc">PMC8160916</ArticleId><ArticleId IdType="pubmed">34042947</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark DE, Parikh A, Dendy JM, et al. COVID-19 myocardial pathology evaluation in athletes with cardiac magnetic resonance (COMPETE CMR) [published correction appears in Circulation. 2021 Feb 9;143(6):e238] Circulation. 2021;143(6):609&#x2013;612. doi: 10.1161/CIRCULATIONAHA.120.052573.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.120.052573</ArticleId><ArticleId IdType="pmc">PMC7864610</ArticleId><ArticleId IdType="pubmed">33332151</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez MW, Tucker AM, Bloom OJ, et al. Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening. JAMA Cardiol. 2021;6(7):745&#x2013;752. doi: 10.1001/jamacardio.2021.0565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2021.0565</ArticleId><ArticleId IdType="pmc">PMC7934073</ArticleId><ArticleId IdType="pubmed">33662103</ArticleId></ArticleIdList></Reference><Reference><Citation>Eiros R, Barreiro-P&#xe9;rez M, Mart&#xed;n-Garc&#xed;a A, et al. Afecci&#xf3;n peric&#xe1;rdica y mioc&#xe1;rdica tras infecci&#xf3;n por SARS-CoV-2: estudio descriptivo transversal en trabajadores sanitarios [Pericardial and myocardial involvement after SARS-CoV-2 infection: a cross-sectional descriptive study in healthcare workers] [published online ahead of print, 2022 Jan 13] Rev Esp Cardiol. 2022 doi: 10.1016/j.recesp.2021.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.recesp.2021.10.021</ArticleId><ArticleId IdType="pmc">PMC8755423</ArticleId><ArticleId IdType="pubmed">35039707</ArticleId></ArticleIdList></Reference><Reference><Citation>Piazza G, Campia U, Hurwitz S, et al. Registry of arterial and venous thromboembolic complications in patients with COVID-19. J Am Coll Cardiol. 2020;76(18):2060&#x2013;2072. doi: 10.1016/j.jacc.2020.08.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.08.070</ArticleId><ArticleId IdType="pmc">PMC7588178</ArticleId><ArticleId IdType="pubmed">33121712</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Albert A, Jacob J, Malchair P, et al. Predictors of revisits within 1 year by patients after acute COVID-19: the HUBCOVID365 cohort study. Predictores de revisita en pacientes con infecci&#xf3;n aguda COVID-19 con seguimiento al a&#xf1;o: estudio de cohorte HUBCOVID365. Emergencias. 2022;34(1):38&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">35103442</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022;&#x2022; Writing Committee, Gluckman TJ, Bhave NM, et al. 2022 ACC Expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022;79(17):1717&#x2013;1756. 10.1016/j.jacc.2022.02.003. This is the expert decision pathway released by the American College of Cardiology on the topic of cardiovascular sequelae of COVID-19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8926109</ArticleId><ArticleId IdType="pubmed">35307156</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x2022; Writing Committee Members, Gulati M, Levy PD, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;78(22):e187-e285. 10.1016/j.jacc.2021.07.053. This is the consensus statement by leading organizations on clinical practice guidelines regarding the evaluation and diagnosis of chest pain. These guidelines should continue to be followed when performing an ischemic evaluation in the setting of cardiovascular sequelae due to COVID-19 infection.</Citation><ArticleIdList><ArticleId IdType="pubmed">34756653</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorecka M, McCann GP, Berry C, et al. Demographic, multi-morbidity and genetic impact on myocardial involvement and its recovery from COVID-19: protocol design of COVID-HEART-a UK, multicentre, observational study. J Cardiovasc Magn Reson. 2021;23(1):77. doi: 10.1186/s12968-021-00752-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-021-00752-1</ArticleId><ArticleId IdType="pmc">PMC8190746</ArticleId><ArticleId IdType="pubmed">34112195</ArticleId></ArticleIdList></Reference><Reference><Citation>Ar&#xe9;valos V, Ortega-Paz L, Fernandez-Rodr&#xed;guez D, et al. Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: a structured summary of a study protocol. PLoS ONE. 2021;16(7):e0255263. doi: 10.1371/journal.pone.0255263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0255263</ArticleId><ArticleId IdType="pmc">PMC8320971</ArticleId><ArticleId IdType="pubmed">34324524</ArticleId></ArticleIdList></Reference><Reference><Citation>Besnier F, B&#xe9;rub&#xe9; B, Malo J, et al. Cardiopulmonary rehabilitation in long-COVID-19 patients with persistent breathlessness and fatigue: the COVID-Rehab Study. Int J Environ Res Public Health. 2022;19(7):4133. doi: 10.3390/ijerph19074133.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19074133</ArticleId><ArticleId IdType="pmc">PMC8998214</ArticleId><ArticleId IdType="pubmed">35409815</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>